The acid ceramidase/ceramide axis controls parasitemia in Plasmodium yoelii-infected mice by regulating erythropoiesis

  1. Anne Günther
  2. Matthias Hose
  3. Hanna Abberger
  4. Fabian Schumacher
  5. Ylva Veith
  6. Burkhard Kleuser
  7. Kai Matuschewski
  8. Karl Sebastian Lang
  9. Erich Gulbins
  10. Jan Buer
  11. Astrid Westendorf
  12. Wiebke Hansen  Is a corresponding author
  1. University of Duisburg-Essen, Germany
  2. Freie Universität Berlin, Germany
  3. Humboldt-Universität zu Berlin, Germany

Abstract

Acid ceramidase (Ac) is part of the sphingolipid metabolism and responsible for the degradation of ceramide. As bioactive molecule, ceramide is involved in the regulation of many cellular processes. However, the impact of cell-intrinsic Ac activity and ceramide on the course of Plasmodium infection remains elusive. Here, we use Ac-deficient mice with ubiquitously increased ceramide levels to elucidate the role of endogenous Ac activity in a murine malaria model. Interestingly, ablation of Ac leads to alleviated parasitemia associated with decreased T cell responses in the early phase of Plasmodium yoelii (P. yoelii) infection. Mechanistically, we identified dysregulated erythropoiesis with reduced numbers of reticulocytes, the preferred host cells of P. yoelii, in Ac-deficient mice. Furthermore, we demonstrate that administration of the Ac inhibitor carmofur to wild type mice has similar effects on P. yoelii infection and erythropoiesis. Notably, therapeutic carmofur treatment after manifestation of P. yoelii infection is efficient in reducing parasitemia. Hence, our results provide evidence for the involvement of Ac and ceramide in controlling P. yoelii infection by regulating red blood cell development.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting file.; Source Data files have been provided for all Figures and Figure Supplements.

Article and author information

Author details

  1. Anne Günther

    Institute of Medical Microbiology, University of Duisburg-Essen, Essen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  2. Matthias Hose

    Institute of Medical Microbiology, University of Duisburg-Essen, Essen, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0746-5591
  3. Hanna Abberger

    Institute of Medical Microbiology, University of Duisburg-Essen, Essen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  4. Fabian Schumacher

    Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8703-3275
  5. Ylva Veith

    Institute of Biology, Humboldt-Universität zu Berlin, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  6. Burkhard Kleuser

    Institute of Pharmacy, Freie Universität Berlin, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Kai Matuschewski

    Institute of Biology, Humboldt-Universität zu Berlin, Berlin, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6147-8591
  8. Karl Sebastian Lang

    Institute of Immunology, University of Duisburg-Essen, Essen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Erich Gulbins

    Institute of Molecular Biology, University of Duisburg-Essen, Essen, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Jan Buer

    Institute of Medical Microbiology, University of Duisburg-Essen, Essen, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-7602-1698
  11. Astrid Westendorf

    Institute of Medical Microbiology, University of Duisburg-Essen, Duisburg, Germany
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2121-2892
  12. Wiebke Hansen

    Institute of Medical Microbiology, University of Duisburg-Essen, Essen, Germany
    For correspondence
    wiebke.hansen@uk-essen.de
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6020-0886

Funding

Deutsche Forschungsgemeinschaft (GRK2098)

  • Karl Sebastian Lang
  • Erich Gulbins
  • Jan Buer
  • Astrid Westendorf
  • Wiebke Hansen

Deutsche Forschungsgemeinschaft (GRK2581)

  • Burkhard Kleuser

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All experiments were performed in strict accordance with the guidelines of the German Animal Protection Law and approved by the State Agency for Nature, Environment, and Consumer Protection (LANUV), North Rhine-Westphalia, Germany (Az 84-02.04.2015.A474, Az 81-02.04.2018.A302).

Copyright

© 2022, Günther et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 784
    views
  • 221
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Anne Günther
  2. Matthias Hose
  3. Hanna Abberger
  4. Fabian Schumacher
  5. Ylva Veith
  6. Burkhard Kleuser
  7. Kai Matuschewski
  8. Karl Sebastian Lang
  9. Erich Gulbins
  10. Jan Buer
  11. Astrid Westendorf
  12. Wiebke Hansen
(2022)
The acid ceramidase/ceramide axis controls parasitemia in Plasmodium yoelii-infected mice by regulating erythropoiesis
eLife 11:e77975.
https://doi.org/10.7554/eLife.77975

Share this article

https://doi.org/10.7554/eLife.77975

Further reading

    1. Microbiology and Infectious Disease
    Dawid S Zyla
    Insight

    A combination of imaging techniques reveals how herpes simplex virus type 1 assembles within infected cells, highlighting the roles of essential viral proteins in viral assembly and exit.

    1. Microbiology and Infectious Disease
    Dhaval Ghone, Edward L Evans ... Aussie Suzuki
    Research Article

    Virion Infectivity Factor (Vif) of the Human Immunodeficiency Virus type 1 (HIV-1) targets and degrades cellular APOBEC3 proteins, key regulators of intrinsic and innate antiretroviral immune responses, thereby facilitating HIV-1 infection. While Vif’s role in degrading APOBEC3G is well-studied, Vif is also known to cause cell cycle arrest, but the detailed nature of Vif’s effects on the cell cycle has yet to be delineated. In this study, we employed high-temporal resolution single-cell live imaging and super-resolution microscopy to monitor individual cells during Vif-induced cell cycle arrest. Our findings reveal that Vif does not affect the G2/M boundary as previously thought. Instead, Vif triggers a unique and robust pseudo-metaphase arrest, distinct from the mild prometaphase arrest induced by Vpr. During this arrest, chromosomes align properly and form the metaphase plate, but later lose alignment, resulting in polar chromosomes. Notably, Vif, unlike Vpr, significantly reduces the levels of both Protein Phosphatase 1 (PP1) and 2 A (PP2A) at kinetochores, which regulate chromosome-microtubule interactions. These results unveil a novel role for Vif in kinetochore regulation that governs the spatial organization of chromosomes during mitosis.